Compass Pathways Plc (CMPS) - Total Liabilities
Based on the latest financial reports, Compass Pathways Plc (CMPS) has total liabilities worth $218.02 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CMPS cash generation efficiency to assess how effectively this company generates cash.
Compass Pathways Plc - Total Liabilities Trend (2018–2024)
This chart illustrates how Compass Pathways Plc's total liabilities have evolved over time, based on quarterly financial data. See CMPS net asset value for net asset value and shareholders' equity analysis.
Compass Pathways Plc Competitors by Total Liabilities
The table below lists competitors of Compass Pathways Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gunkul Engineering Public Company Limited
BK:GUNKUL
|
Thailand | ฿16.68 Billion |
|
Xiangyang Automobile Bearing Co Ltd
SHE:000678
|
China | CN¥1.47 Billion |
|
Kiwetinohk Energy Corp
TO:KEC
|
Canada | CA$395.84 Million |
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
South Africa | ZAC2.00 Million |
|
Rpmglobal Holdings Ltd
AU:RUL
|
Australia | AU$48.30 Million |
|
Nantong Chaoda Equipment Co.Ltd.
SHE:301186
|
China | CN¥690.27 Million |
|
Tungkong Inc
SHE:002117
|
China | CN¥602.53 Million |
|
Qingdao Topscomm Commun Inc
SHG:603421
|
China | CN¥1.07 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Compass Pathways Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Compass Pathways Plc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Compass Pathways Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Compass Pathways Plc (2018–2024)
The table below shows the annual total liabilities of Compass Pathways Plc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $58.97 Million | +17.37% |
| 2023-12-31 | $50.24 Million | +213.74% |
| 2022-12-31 | $16.01 Million | -2.86% |
| 2021-12-31 | $16.49 Million | +139.10% |
| 2020-12-31 | $6.89 Million | -71.12% |
| 2019-12-31 | $23.87 Million | -41.43% |
| 2018-12-31 | $40.75 Million | -- |
About Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more